Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q1 2023 call → NOThe question asks whether management explains the company's business direction by narrating what its counterparties are doing and scaling — specifically, whether a substantial part of the forward account consists of reporting on the growth/expansion/ramp of specific customers/partners the company already supplies, such that the company's own coming volume is presented as a consequence of those parties' trajectories. Let me analyze the transcript carefully. Key elements to check: 1. Does management speak about counterparties' business as part of its own, with real substance about what they're doing? 2. Is the company already inside that growth (already supplying, not bidding)? 3. Is the counterparties' trajectory early and large relative to the company? Let me look at what management actually says about the forward outlook. Kyle's opening remarks: He talks about industry trends — demand for electricity, nuclear renaissance, license extensions, etc. He mentions a CEO of a major utility operator who said he's planning to extend lifetimes and invest. He mentions X-Energy's North States Power in Minnesota applying for a 20-year extension. He mentions Michigan restarting Palisades. He mentions Vogtle 3 going critical. He mentions Westinghouse entering SMR market. But wait — are these counterparties that GSE already supplies? Let me check. - The utility CEO: "I met with the CEO of a major utility operator" — this is a general industry anecdote, not a specific counterparty GSE serves. - X-Energy's North States Power in Minnesota — is this a GSE customer? Not stated. - Palisades in Michigan — not stated as a GSE customer. - Vogtle 3 — "This is a great achievement for Southern Company and the industry and GSE." So GSE was involved with Vogtle. But this is about a completed reactor going critical, not a forward trajectory. - Westinghouse SMR — not a GSE customer relationship described. Then Kyle discusses GSE's own business: new orders, backlog, Performance Engineering division, Workforce Solutions. He talks about the company's own sales efforts, business development, etc. The major deal: "a renewal contract that includes a meaningful expansion of services with two U.S. government engineering laboratories dedicating to supporting the U.S. Navy. This is a five-year contract that has options to make it worth up to $28 million over that time.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.